The Basics of Skull Base Brain Tumors

2023-01-30T08:50:10-05:00

Fabio Frisoli, MD, Director of Skull Base Neurosurgery at the Gerald J. Glasser Brain Tumor Center, shares what patients and caregivers need to know.

The Basics of Skull Base Brain Tumors2023-01-30T08:50:10-05:00

New Vaccine Prolongs Life for Glioblastoma Patients

2023-01-20T16:35:21-05:00

A major phase III clinical trial has found that DCVax®-L, a dendritic cell brain tumor vaccine, can prolong the lives of patients diagnosed with new or recurrent glioblastomas.

New Vaccine Prolongs Life for Glioblastoma Patients2023-01-20T16:35:21-05:00

Changing the Paradigm for the Treatment of Metastatic Lung Cancer in the Brain

2022-07-12T20:00:10-04:00

Survival for patients with brain metastases from lung cancer is increasing – thanks to advancements in immunotherapy and personalized medications that target specific gene mutations, penetrate into the brain and have a high likelihood of success.

Changing the Paradigm for the Treatment of Metastatic Lung Cancer in the Brain2022-07-12T20:00:10-04:00

“SURVIVE” Phase 2B

2022-05-26T19:17:08-04:00

The Glasser Brain Tumor Center is active in many clinical trials in our ongoing quest to enhance our patients’ lives. While all of the trials are inspiring, one of the most exciting is “SURVIVE” Phase 2B. We are the only site in New Jersey and one of the first three in the nation to participate in this trial for a potentially game-changing brain cancer vaccine.

“SURVIVE” Phase 2B2022-05-26T19:17:08-04:00

Next-Generation Sequencing: The Key to Next-Level Brain Tumor Treatment

2023-01-27T16:14:18-05:00

Next-generation sequencing – similar to a search engine that combs through thousands of genes to find abnormalities in the single one that causes a patient’s cancer – is revolutionizing brain cancer care. An intimate understanding of a tumor’s mutations, or lack thereof, means more personalized and effective treatment plans.

Next-Generation Sequencing: The Key to Next-Level Brain Tumor Treatment2023-01-27T16:14:18-05:00

Living with Brian Cancer: Attitude is Everything

2022-05-26T19:41:11-04:00

At 43, Lindsay Vieira was diagnosed with an anaplastic oligodendroglioma, a rare type of cancerous brain tumor. The Glasser Brain Tumor Center team used stereotactic imaging and GPS-like technology – along with electrical stimulation brain mapping – to remove her entire tumor and keep all of her neurological functions intact.

Living with Brian Cancer: Attitude is Everything2022-05-26T19:41:11-04:00

Technology That Is Transforming Brain Surgery

2022-03-30T12:06:57-04:00

When Lisa Vidal was diagnosed with a malignant brain tumor, she did something novel among most brain tumor patients. She drank a pink liquid that made her tumor glow, empowering our neurosurgeons to safely remove her tumor with pinpoint accuracy.

Technology That Is Transforming Brain Surgery2022-03-30T12:06:57-04:00
Go to Top